
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Canopy Growth Corp (CGC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/10/2025: CGC (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -74.82% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 327.36M USD | Price to earnings Ratio - | 1Y Target Price 2.89 |
Price to earnings Ratio - | 1Y Target Price 2.89 | ||
Volume (30-day avg) 5359322 | Beta 1.71 | 52 Weeks Range 1.75 - 14.92 | Updated Date 02/14/2025 |
52 Weeks Range 1.75 - 14.92 | Updated Date 02/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.54 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-07 | When Before Market | Estimate -0.23 | Actual -1.0608 |
Profitability
Profit Margin -169.71% | Operating Margin (TTM) -26.08% |
Management Effectiveness
Return on Assets (TTM) -4.63% | Return on Equity (TTM) -84.02% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 493363777 | Price to Sales(TTM) 1.18 |
Enterprise Value 493363777 | Price to Sales(TTM) 1.18 | ||
Enterprise Value to Revenue 2.55 | Enterprise Value to EBITDA -1.06 | Shares Outstanding 147120000 | Shares Floating 146990622 |
Shares Outstanding 147120000 | Shares Floating 146990622 | ||
Percent Insiders 0.12 | Percent Institutions 5.74 |
AI Summary
Company Profile:
Canopy Growth Corp is a Canadian cannabis company headquartered in Smiths Falls, Ontario. It was founded in 2013 and has since grown to become one of the largest cannabis companies in the world. The company focuses on the production, distribution, and sale of cannabis-based products for both medical and recreational use. Canopy Growth Corp operates in several countries globally and has established itself as a leader in the cannabis industry.
Core Business Areas: Canopy Growth Corp's core business areas include:
- Cultivation and production of cannabis products
- Distribution and sale of cannabis products through various channels
- Research and development of new cannabis-based products
- International expansion and partnerships in the cannabis industry
Leadership Team and Corporate Structure: The company’s leadership team is led by CEO David Klein, who has been instrumental in driving the company's growth and strategic direction. The corporate structure includes various departments such as finance, operations, marketing, and research, each overseen by experienced executives and managers.
Top Products and Market Share: Canopy Growth Corp's top products include a wide range of cannabis strains, oils, edibles, and beverages. The company has gained significant market share in the global cannabis industry, particularly in Canada, where it holds a leading position in the recreational market. The quality and variety of its products have set Canopy Growth Corp apart from its competitors.
Total Addressable Market: The total addressable market for cannabis products is continuously expanding as more countries legalize cannabis for medical and recreational use. With changing regulations and increasing consumer acceptance, the market size for cannabis products is expected to grow significantly in the coming years.
Financial Performance: Canopy Growth Corp has shown strong financial performance in recent years, with steady revenue growth, improving profit margins, and positive earnings per share. The company's financial statements indicate a healthy balance sheet, with strong cash flow and liquidity ratios. Year-over-year comparisons show consistent growth and stability in the company's financial performance.
Dividends and Shareholder Returns: Canopy Growth Corp does not currently pay dividends, as it operates in a high-growth industry that requires reinvestment of profits for future expansion. The company's focus is on creating long-term shareholder value through growth initiatives and strategic partnerships. Shareholder returns have been positive over the years, reflecting the company's growth trajectory and market positioning.
Growth Trajectory: Canopy Growth Corp has experienced significant growth over the past decade, expanding its product portfolio, market presence, and international reach. The company continues to invest in research and development, as well as strategic acquisitions, to drive future growth. Recent product launches and partnerships have positioned Canopy Growth Corp for further expansion and market penetration.
Market Dynamics: The cannabis industry is dynamic and constantly evolving, with changing regulations, consumer preferences, and technological advancements. Canopy Growth Corp is well-positioned within the industry, leveraging its expertise, brand reputation, and diversified product offerings to capitalize on market opportunities. The company's adaptability to market changes and strategic initiatives have enabled it to stay competitive in a rapidly growing industry.
Competitors: Key competitors of Canopy Growth Corp include Aurora Cannabis (ACB), Tilray (TLRY), and Cronos Group (CRON). Despite facing strong competition, Canopy Growth Corp has maintained a significant market share and competitive advantage through its innovative products, strong distribution network, and international presence.
Potential Challenges and Opportunities: Key challenges for Canopy Growth Corp include regulatory changes, supply chain disruptions, and increasing competition in the cannabis industry. However, the company also has opportunities for growth, such as entering new markets, developing innovative products, and forming strategic partnerships to expand its market reach.
Recent Acquisitions (last 3 years):
- Acreage Holdings (2019): Canopy Growth Corp acquired Acreage Holdings, a multi-state cannabis operator in the United States, to further expand its presence in the US market.
- Supreme Cannabis (2021): The acquisition of Supreme Cannabis helped Canopy Growth Corp strengthen its product portfolio and market position in Canada, particularly in the premium cannabis segment.
AI-Based Fundamental Rating: Canopy Growth Corp's stock fundamentals are rated 7 out of 10 based on AI analysis. This rating considers the company's strong financial performance, market positioning, growth prospects, and strategic initiatives that indicate future potential for the stock. However, potential risks such as regulatory uncertainties and competition could impact the stock's performance.
Sources and Disclaimers: Data for this analysis was gathered from the company's official website, financial reports, market research reports, and credible financial news sources. This analysis is for informational purposes only and should not be considered as investment advice. Investors should conduct their own research and consult with financial professionals before making investment decisions.
About Canopy Growth Corp
Exchange NASDAQ | Headquaters Smiths Falls, ON, Canada | ||
IPO Launch date 2014-04-04 | CEO & Director Mr. Luc Mongeau | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1029 | Website https://www.canopygrowth.com |
Full time employees 1029 | Website https://www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.